Nashaat (Nash) T. Nashed, Ph.D., is a chemical biotechnology patent agent in the firm's Chemical Patent Prosecution group. His practice focuses on client counseling and patent prosecution involving a wide range of technologies including recombinant DNA technology, genetics, immunology, enzymology, medical diagnostics, three-dimensional structure of proteins and nucleic acids, small organic molecules, organic synthesis, spectroscopy, and separation methods. Dr. Nashed has particular expertise in the medical, biotechnology, and pharmaceutical fields.
Prior to joining the firm, Dr. Nashed was a primary patent examiner and supervisory patent examiner at the U. S. Patent and Trademark Office. He examined patent applications related to peptides, enzymes, three-dimensional structure of proteins, and designed metabolic pathway and their host cells. Also, he was a research chemist in the Laboratory of Bioorganic Chemistry of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and research associate at the Department of Chemistry at the University of Chicago. He conducted research in physical organic chemistry and enzymology, and published 28 scientific papers published in peer reviewed journals.
- New York University (Ph.D.)
- Bio Organic Chemistry
- New York University (M.S.)
- Organic Chemistry
- Ain Shams University (B.Sc.)
- Chemistry and Geology
- Registered to practice before the U.S. Patent and Trademark Office
- U. S. Department of Commerce Exceptional Career Award for Outstanding Performance and Service (2008).
- U. S. Department of Commerce Bronze Medal for Superior Federal Service (2004).
“Kinetics and mechanism of auto processing HIV-1 protease from an analog of the Gag-Pol polyprotein.” Proceedings of the National Academy of Science U. S. A. 1994, 91, 7970-7974.
“Sterically induced methods migration on acid catalyzed dehydration of K-region trans-dihydrodiol monomethylether.” Journal of Organic Chemistry 1993, 58, 6344-6348.
“Methanolysis of K-region arene oxides: comparison between the acid catalyzed and methoxide addition reaction.” Journal of the American Chemical Society 1993, 115, 1711-1722.
“7-Dehydrocholesterol 5,6β as a mechanism based inhibitor of microsomal cholesterol epoxide hydrolase.” Journal of Biological Chemistry.” 1986, 261, 2510-2513.
“Carboxypeptidase A-catalyzed ⍺,β-elimination reaction: rapid catalysis of ⍺,β-elimination of hydrogen chloride from β-chloroketon substrates. Journal of the American Chemical Society 1986, 108, 2710-2715.